3The application of electrophysiological functional target localization in surgery for Parkinson's disease270-273
6Clinical efficacy of selegiline added to levodopa/decarboxylase inhibitor in Parkinson's disease281-284
8The relationship between cerebral vasospasm and vasoactive substances after subarachnoid hemorrhage292-294
10The relationship between the polymorphism of toxicant metabolic enzyme and hereditary susceptibility of Parkinson's disease297-300